Breast Cancer Clinical Trial

Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients

Summary

Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka "lumpectomy") or a total mastectomy.

The investigators hypothesize that routine shave margins during partial mastectomy will significantly reduce positive margin rate. A positive margin means that cancerous cells were detected at the edge of the excised area. This generally mandates a return to the operating room for re-excision.

View Full Description

Full Description

Some authors have investigated, in a retrospective fashion, the use of routine shave margins, where surgeons routinely take additional margins at the time of the initial partial mastectomy as a means of obtaining negative margins. While these retrospective studies have found that positive margin rates declined using this technique, opponents to this technique wonder if this truly results in a higher negative margin rate without compromising cosmesis or increasing tissue volume removed. As these studies were retrospective, it was possible that the initial resection was smaller than what those who do not routinely take shave margins would resect. No one had evaluated the impact of further resection on operative time, nor in a blinded fashion, evaluated cosmesis. Further, there had yet to be a prospective study to evaluate the impact of this on local recurrence rates. Hence, the investigators performed a prospective randomized controlled trial of this technique at Yale. The data from this study, published in the New England Journal of Medicine, found that the technique cut positive margin and re-excision rates in half. Some wondered, however, about the external generalizability of these findings, particularly in non-academic settings. Hence, a multicenter trial to validate these findings is warranted.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Breast cancer, stage 0-3, deemed a surgically appropriate candidate for partial mastectomy with planned procedure for the same
Women ≥ 18 years of age
Ability to understand and the willingness to sign a written informed consent document.

Exlusion Criteria

Total mastectomy
Known metastatic disease
Bilateral synchronous breast cancer
Multicentric cancers requiring double lumpectomy
Previous history of breast cancer (even in the other breast)
Patients receiving Intraoperative radiation therapy (IORT)
Patients who had excisional biopsy for diagnosis of their cancer (I.e., instead of a core biopsy)

Study is for people with:

Breast Cancer

Estimated Enrollment:

400

Study ID:

NCT02772731

Recruitment Status:

Active, not recruiting

Sponsor:

Yale University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 9 Locations for this study

See Locations Near You

Loma Linda University Cancer Center
Loma Linda California, 92354, United States
Watson Clinic Cancer and Research Center
Lakeland Florida, 33805, United States
William Beaumont Hospital
Troy Michigan, 48085, United States
UNC Chapel Hill
Chapel Hill North Carolina, 27599, United States
Wake Forest School of Medicine
Winston-Salem North Carolina, 27157, United States
Cleveland Clinic Akron General
Akron Ohio, 44307, United States
Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States
Women & Infants Hospital
Providence Rhode Island, 02905, United States
Doctors Hospital at Renaissance
Edinburg Texas, 78539, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

400

Study ID:

NCT02772731

Recruitment Status:

Active, not recruiting

Sponsor:


Yale University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.